Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Lena, Alessia (57204551352)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Recent advances in cardio-oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’
    (2019)
    Anker, Markus S. (35763654100)
    ;
    Hadzibegovic, Sara (57204551985)
    ;
    Lena, Alessia (57204551352)
    ;
    Belenkov, Yury (7006528098)
    ;
    Bergler-Klein, Jutta (56019537300)
    ;
    de Boer, Rudolf A. (8572907800)
    ;
    Farmakis, Dimitrios (55296706200)
    ;
    von Haehling, Stephan (6602981479)
    ;
    Iakobishvili, Zaza (6603020069)
    ;
    Maack, Christoph (6701763468)
    ;
    Pudil, Radek (57210201747)
    ;
    Skouri, Hadi (21934953600)
    ;
    Cohen-Solal, Alain (57189610711)
    ;
    Tocchetti, Carlo G. (6507913481)
    ;
    Coats, Andrew J.S. (35395386900)
    ;
    Seferović, Petar M. (6603594879)
    ;
    Lyon, Alexander R. (57203046227)
    While anti-cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and targeted therapy, are constantly advancing, cardiovascular toxicity has become a major challenge for cardiologists and oncologists. This has led to an increasing demand of cardio-oncology units in Europe and a growing interest of clinicians and researchers. The Heart Failure 2019 meeting of the Heart Failure Association of the European Society of Cardiology in Athens has therefore created a scientific programme that included four dedicated sessions on the topic along with several additional lectures. The major points that were discussed at the congress included the implementation and delivery of a cardio-oncology service, the collaboration among cardio-oncology experts, and the risk stratification, prevention, and early recognition of cardiotoxicity. Furthermore, sessions addressed the numerous different anti-cancer therapies associated with cardiotoxic effects and provided guidance on how to treat cancer patients who develop cardiovascular disease before, during, and after treatment. © 2019 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians
    (2020)
    Anker, Markus S. (35763654100)
    ;
    Bouleti, Claire (36917910800)
    ;
    Christodoulides, Theodoros (22936948500)
    ;
    Durante, Angela (57205176368)
    ;
    Gara, Edit (55932148600)
    ;
    Hadzibegovic, Sara (57204551985)
    ;
    Keramida, Kalliopi (57202300032)
    ;
    Lena, Alessia (57204551352)
    ;
    Massouh, Angela (55553153100)
    ;
    Milinkovic, Ivan (51764040100)
    ;
    Nägele, Matthias P. (56677577400)
    ;
    Nossikoff, Alexander (9739459100)
    ;
    Plácido, Rui (18438045300)
    ;
    Radovits, Tamás (12239504400)
    ;
    Tolppanen, Heli (32668130000)
    ;
    Vergaro, Giuseppe (23111620200)
    ;
    Wallner, Markus (57188564841)
    ;
    Welch, Sophie (57216657135)
    ;
    Lopatin, Yuri (6601956122)
    ;
    Lainscak, Mitja (9739432000)
    ;
    Mebazaa, Alexandre (57210091243)
    ;
    Coats, Andrew J.S. (35395386900)
    ;
    Seferović, Petar M. (6603594879)
    ;
    Jankowska, Ewa A. (21640520500)
    The “Heart failure specialists of Tomorrow” (HoT) group gathers young researchers, physicians, basic scientists, nurses and many other professions under the auspices of the Heart Failure Association of the European Society of Cardiology. After its foundation in 2014, it has quickly grown to a large group of currently 925 members. Membership in this growing community offers many advantages during, before, and after the ‘Heart Failure and World Congress on Acute Heart Failure’. These include: eligibility to receive travel grants, participation in moderated poster sessions and young researcher and clinical case sessions, the HoT walk, the career café, access to the networking opportunities, and interaction with a large and cohesive international community that constantly seeks multinational collaborations. © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback